Pfizer Manufacturing Belgium NV
Pfizer Manufacturing Belgium NV is a drug establishment in Puurs-Sint-Amands, Belgium, registered with the US FDA under FEI 1000654629. Its registered operations are: Analytical testing, Labelling, Drug manufacture, Packaging. 38 EU/UK GMP certificates are matched to this site, 31 inspected within the last three years.
Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology
Registered operations
Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.
GMP documents matched to this site (38)
| Document | Authority | Inspection | Source |
|---|---|---|---|
BE/GMP/2025/143 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/151 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/149 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/150 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/147 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/152 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/145 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/134 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/136 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/144 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/141 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/142 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/212 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/146 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/148 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2025/135 GMP certificate | Competent authority of Belgium | 22 Oct 2025 within 3-year review window | EudraGMDP |
BE/GMP/2024/117 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/123 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/038 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/121 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/122 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/120 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/118 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/040 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/115 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/124 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/113 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/114 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/039 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/116 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2024/119 GMP certificate | Competent authority of Belgium | 21 Mar 2024 within 3-year review window | EudraGMDP |
BE/GMP/2023/119 GMP certificate | Competent authority of BELGIUM | 6 Oct 2023 outside 3-year review window | EudraGMDP |
BE/GMP/2023/085 GMP certificate | Competent authority of BELGIUM | 6 Oct 2023 outside 3-year review window | EudraGMDP |
BE/GMP/2023/083 GMP certificate | Competent authority of BELGIUM | 6 Oct 2023 outside 3-year review window | EudraGMDP |
BE/GMP/2023/084 GMP certificate | Competent authority of BELGIUM | 6 Oct 2023 outside 3-year review window | EudraGMDP |
BE/GMP/2023/120 GMP certificate | Competent authority of BELGIUM | 6 Oct 2023 outside 3-year review window | EudraGMDP |
BE/GMP/2022/100 GMP certificate | Competent authority of Belgium | 25 Nov 2022 outside 3-year review window | EudraGMDP |
BE/GMP/2021/174 GMP certificate | Competent authority of Belgium | 4 Jun 2021 outside 3-year review window | EudraGMDP |
A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.
What this page does not show
- Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
- Capacity, scale, price or current availability: no regulator publishes these.
- FDA inspection classifications for this site, which are not yet linked.
Other sites registered by the same company
- Pfizer Asia Manufacturing Pte LtdSingapore, Singapore · API manufacture
- Pfizer Health ABStrangnas, Sweden · API manufacture
- Pfizer IncChesterfield, United States · API manufacture
- Pfizer Ireland Pharmaceuticals Unlimited CompanyRINGASKIDDY, Ireland · API manufacture
- Pfizer Manufacturing Austria GmbHOrth an der Donau, Austria · API manufacture
- Pfizer Manufacturing Deutschland GmbHFreiburg im Breisgau, Germany
- Pharmacia & Upjohn Company LLCKalamazoo, United States · API manufacture
- Pharmacia Hepar LLCFranklin, United States · API manufacture